Skip to main content
FinSpry Logo
FinSpry
BFRI logo
BFRI
(NASDAQ)
Biofrontera Inc.
$0.81-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Biofrontera (BFRI) Stock Price & Financial Analysis

Biofrontera Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.78 - $0.83
52-Week High$1.19
52-Week Low$0.54
Open$0.78
Volume148.30K
Average Volume (3M)215.36K
Market Cap9.25M
Shares Outstanding11.65M
Price to Sales (P/S)0.22
Price to Book (P/B)0.89
EV/EBITDA-0.89
Revenue (TTM)41.71M
Net Income (TTM)-10.54M
Free Cash Flow (TTM)-13.36M
EPS (TTM)$-1.04
Profit Margin-25.26%
Operating Margin-27.20%
Return on Equity (ROE)-100.53%
Debt to Equity0.47
50-Day MA$0.98
200-Day MA$0.92
52-Week Change62.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Biofrontera

What is the current stock price for BFRI?

As of the latest trading session, BFRI stock trades at $0.81. The 52-week range is $0.54–$1.19, with a day range of $0.78–$0.83.

What is the P/E ratio for BFRI?

The P/E ratio (Price-to-Earnings) for BFRI is shown in the Key Statistics section. This valuation metric helps compare Biofrontera Inc. to industry peers.

Does BFRI pay dividends?

Biofrontera does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BFRI?

Based on 1 analyst, the consensus for BFRI is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BFRI?

Biofrontera's market capitalization is $9.4M, classifying it as a micro-cap company. Biofrontera operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.